| Wilson Tyler Walker, MD | |
|
1200 Memorial Dr, Dalton, GA 30720-2529 | |
| (706) 272-6150 | |
| Not Available |
| Full Name | Wilson Tyler Walker |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 1200 Memorial Dr, Dalton, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609221282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 83607 (Georgia) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hamilton Medical Center | Dalton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Coverage Corp | 3072412592 | 364 |
News Archive
For millions of people who live under the constant threat of Leishmania infection, a new discovery by Brazilian scientists may lead to new breakthroughs, preventing these parasites from taking hold in the body or reducing the severity of infections once they occur.
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.
The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets, according to a scientific paper by the Translational Genomics Research Institute published this month in the journal Molecular Cancer.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
Giving iron supplements to children with marginally low birth weights (2000-2500 grams) dramatically reduces the risk of developing iron deficiency and anemia. This is shown by Umeå researcher Magnus Domellöf and associates in the coming edition of the pediatric scientific journal Pediatrics.
› Verified 1 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050411000056 |
News Archive
For millions of people who live under the constant threat of Leishmania infection, a new discovery by Brazilian scientists may lead to new breakthroughs, preventing these parasites from taking hold in the body or reducing the severity of infections once they occur.
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.
The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets, according to a scientific paper by the Translational Genomics Research Institute published this month in the journal Molecular Cancer.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
Giving iron supplements to children with marginally low birth weights (2000-2500 grams) dramatically reduces the risk of developing iron deficiency and anemia. This is shown by Umeå researcher Magnus Domellöf and associates in the coming edition of the pediatric scientific journal Pediatrics.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilson Tyler Walker, MD 1200 Memorial Dr, Dalton, GA 30720-2529 Ph: (706) 272-6150 | Wilson Tyler Walker, MD 1200 Memorial Dr, Dalton, GA 30720-2529 Ph: (706) 272-6150 |
News Archive
For millions of people who live under the constant threat of Leishmania infection, a new discovery by Brazilian scientists may lead to new breakthroughs, preventing these parasites from taking hold in the body or reducing the severity of infections once they occur.
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I.
The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets, according to a scientific paper by the Translational Genomics Research Institute published this month in the journal Molecular Cancer.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
Giving iron supplements to children with marginally low birth weights (2000-2500 grams) dramatically reduces the risk of developing iron deficiency and anemia. This is shown by Umeå researcher Magnus Domellöf and associates in the coming edition of the pediatric scientific journal Pediatrics.
› Verified 1 days ago
Erin Nicole Graw, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Memorial Dr, Dalton, GA 30720 Phone: 706-272-6000 | |
James Francis Wojcik, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Memorial Dr, Dalton, GA 30720 Phone: 706-278-2105 Fax: 865-291-3228 | |
Justin Hare, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1525 Chattanooga Rd, Dalton, GA 30720 Phone: 706-529-7124 Fax: 706-529-7126 | |
Jennifer Dark Starnes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1508 N Thornton Ave, Dalton, GA 30720 Phone: 706-272-6158 | |
Jan Renee Mayfield, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 Memorial Dr, Dalton, GA 30720 Phone: 706-278-2105 Fax: 865-291-3228 | |
Shawn Holsonback, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Memorial Dr, Dalton, GA 30720 Phone: 706-272-6000 | |
David E Ruiz, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1107 Memorial Dr, Suite 201, Dalton, GA 30720 Phone: 706-277-7311 Fax: 706-529-4837 |